Investigating how fibroblast growth factor signaling can protect against pulmonary hypertension caused by low oxygen levels

Who could benefit from this research

What this research studies

This research focuses on understanding the mechanisms behind pulmonary hypertension, particularly how fibroblast growth factor (FGF) signaling can help protect blood vessels from damage caused by low oxygen levels. The principal investigator, Dr. Kel Vin Woo, will explore how FGF signaling affects the behavior of cells in blood vessels and may lead to new therapies using adenovirus to deliver FGF to the affected areas. Patients may benefit from innovative treatments that improve their condition and overall health outcomes.

Why it matters

Where this research is happening

• Washington University
  Saint Louis, United States Active

Researchers

• Principal investigator: Woo, Kelvin — Washington University
• Study coordinator: Woo, Kelvin

Related research

Other NIH-funded projects on the same topics.

• FGF signaling and vascular remodeling in lung hypertension

  A doctor-scientist at Washington University is studying how fibroblast growth factor (FGF) signaling affects pulmonary hypertension and exploring new potential therapies.

  NIH research Washington University · Saint Louis, United States · NIH-11392512

• Understanding how certain immune cells contribute to lung problems caused by schistosomiasis.

  This study is looking at how a specific protein in immune cells affects their energy use and may contribute to lung problems caused by schistosomiasis, with the goal of finding new ways to help treat this condition.

  NIH research University of California, San Francisco · San Francisco, United States · NIH-11046623

• Investigating how a specific enzyme contributes to lung disease caused by low oxygen levels.

  This study is looking at how a specific enzyme affects lung cells in people with pulmonary arterial hypertension (PAH), which is a serious lung condition, to find new ways to help treat it.

  NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11031309

• Understanding how low oxygen levels during pregnancy affect newborn lung health

  This study is looking at how not getting enough oxygen in the womb might cause high blood pressure in the lungs of newborns, and it aims to understand how a certain part of the lungs works to help with blood flow, which could lead to better treatments for babies who are affected.

  NIH research Loma Linda University · Loma Linda, UNITED STATES · NIH-10993588

• Understanding how certain immune cells contribute to high blood pressure in the lungs caused by low oxygen levels.

  This study is looking at how certain immune cells in your body might affect high blood pressure in the lungs caused by low oxygen levels, with the hope of finding new ways to help people who have this condition.

  NIH research University of Colorado Denver · Aurora, UNITED STATES · NIH-10914166

• Understanding how CD4 T cells fuel schistosomiasis-related lung disease

  A study explores how specific immune cells and inflammatory signals in schistosomiasis may contribute to pulmonary hypertension in people affected by the disease.

  NIH research University of California, San Francisco · San Francisco, United States · NIH-11606580

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.